Oncogenic miR-544 is an important molecular target in gastric cancer

Anti-Cancer Agents in Medicinal Chemistry

Volumn 13, Issue 2, 2013, Pages 270-275

  Zhi, Qiaoming ^a   Guo, Xiaobo ^a,b   Guo, Lei ^a   Zhang, Rongjuan ^a   Jiang, Jinling ^a   Ji, Jun ^a   Zhang, Jianian ^a   Zhang, Jun ^a   Chen, Xuehua ^a   Cai, Qu ^a   Li, Jianfang ^a   Liu, Bingya ^a   Zhu, Zhenggang ^a   Yu, Yingyan ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANDONG PROVINCIAL HOSPITAL AFFILIATED TO SHANDONG UNIVERSITY   (China)

Author keywords

Gastric cancer; IRX1; MiR 544; Oncogenic microRNA

Indexed keywords

MICRORNA; MICRORNA 544; UNCLASSIFIED DRUG;

ARTICLE; BIOLOGICAL ACTIVITY; CELL CYCLE; CELL CYCLE PROGRESSION; CELL GROWTH; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; FLOW CYTOMETRY; GENE; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; IRX 1 GENE; MOLECULARLY TARGETED THERAPY; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; STOMACH CANCER; WESTERN BLOTTING;

CELL CYCLE; CELL LINE; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; MOLECULAR TARGETED THERAPY; RNA, NEOPLASM; STOMACH NEOPLASMS;

EID: 84876702008     PISSN: 18715206     EISSN: 18755992     Source Type: Journal    
DOI: 10.2174/1871520611313020013     Document Type: Article

References (25)

1. Lagos-Quintana, M.; Rauhut, R.; Lendeckel, W.; Tuschl, T. Identification of novel genes coding for small expressed RNAs. Science, 2001, 294, 853-858.
2. Lau, N. C.; Lim, L. P.; Weinstein, E. G.; Bartel, D. P. An abundant class of tiny RNAs with probable regulatory roles in Caenorhabditis elegans. Science, 2001, 294, 858-862.
3. Lee, R. C.; Ambros, V. An extensive class of small RNAs in Caenorhabditis elegans. Science, 2001, 294, 862-864.
4. Bueno, M. J.; de Castro, I. P.; Malumbres, M. Control of cell proliferation pathways by microRNAs. Cell Cycle, 2008, 7, 3143-3148.
5. Cho, W. C. OncomiRs: the discovery and progress of microRNAs in cancers. Mol. Cancer, 2007, 6, 60.
6. Parkin, D. M.; Bray, F.; Ferlay, J.; Pisani, P. Global cancer statistics, 2002. CA Cancer J. Clin., 2005, 55, 74-108.
7. Saka, M.; Katai, H.; Fukagawa, T.; Nijjar, R.; Sano, T. Recurrence in early gastric cancer with lymph node metastasis. Gastric Cancer, 2008, 11, 214-218.
8. Tamura, G. Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer. World J. Gastroenterol., 2006, 12, 192-198.
9. Guo, X.; Liu, W.; Pan, Y.; Ni, P.; Ji, J.; Guo, L.; Zhang, J.; Wu, J.; Jiang, J.; Chen, X.; Cai, Q.; Li, J.; Gu, Q.; Liu, B.; Zhu, Z.; Yu, Y. Homeobox gene IRX1 is a tumor suppressor gene in gastric carcinoma. Oncogene, 2010, 29, 3908-3920.
10. Guo, X. B.; Guo, L.; Zhi, Q. M.; Ji, J.; Jiang, J. L.; Zhang, R. J.; Zhang, J. N.; Zhang, J.; Chen, X. H.; Cai, Q.; Li, J. F.; Yan, M.; Gu, Q. L.; Liu, B. Y.; Zhu, Z. G.; Yu, Y. Y. H. Pylori induces promoter hypermethylation and downregulates gene expression of IRX1 transcription factor on human gastric mucosa. J. Gastroenterol. Hepatol., 2011, 26, 1685-1690.
11. Lu, Y.; Yu, Y.; Zhu, Z.; Xu, H.; Ji, J.; Bu, L.; Liu, B.; Jiang, H.; Lin, Y.; Kong, X.; Hu, L. Identification of a new target region by loss of heterozygosity at 5p15.33 in sporadic gastric carcinomas: genotype and phenotype related. Cancer Lett., 2005, 224, 329-337.
12. Jiang, J.; Liu, W.; Guo, X.; Zhang, R.; Zhi, Q.; Ji, J.; Zhang, J.; Chen, X.; Li, J.; Gu, Q.; Liu, B.; Zhu, Z.; Yu, Y. IRX1 influences peritoneal spreading and metastasis via inhibiting BDKRB2-dependent neovascularization on gastric cancer. Oncogene, 2011, 30, 4498-4508.
13. Iizuka, N.; Oka, M.; Yamada-Okabe, H.; Nishida, M.; Maeda, Y.; Mori, N.; Takao, T.; Tamesa, T.; Tangoku, A.; Tabuchi, H.; Hamada, K.; Nakayama, H.; Ishitsuka, H.; Miyamoto, T.; Hirabayashi, A.; Uchimura, S.; Hamamoto, Y. Oligonucleotide microarray for prediction of early intrahepatic recurrence of hepatocellular carcinoma after curative resection. Lancet, 2003, 361, 923-929.
14. Roberts, L. R.; Gores, G. J. Hepatocellular carcinoma: molecular pathways and new therapeutic targets. Semin Liver Dis., 2005, 25, 212-225.
15. Bennett, K. L.; Karpenko, M.; Lin, M. T.; Claus, R.; Arab, K.; Dyckhoff, G.; Plinkert, P.; Herpel, E.; Smiraglia, D.; Plass, C. Frequently methylated tumor suppressor genes in head and neck squamous cell carcinoma. Cancer Res., 2008, 68, 4494-4499.
16. Bennett, K. L.; Lee, W.; Lamarre, E.; Zhang, X.; Seth, R.; Scharpf, J.; Hunt, J.; Eng, C. HPV status-independent association of alcohol and tobacco exposure or prior radiation therapy with promoter methylation of FUSSEL18, EBF3, IRX1, and SEPT9, but not SLC5A8, in head and neck squamous cell carcinomas. Genes Chromosomes Cancer, 2010, 49, 319-326.
17. Becker, M. B.; Zulch, A.; Bosse, A.; Gruss, P. Irx1 and Irx2 expression in early lung development. Mech. Dev., 2001, 106, 155-158.
18. Alarcon, P.; Rodriguez-Seguel, E.; Fernandez-Gonzalez, A.; Rubio, R.; Gomez-Skarmeta, J. L. A dual requirement for Iroquois genes during Xenopus kidney development. Development, 2008, 135, 3197-3207.
19. Guo, X.; Guo, L.; Ji, J.; Zhang, J.; Chen, X.; Cai, Q.; Li, J.; Gu, Q.; Liu, B.; Zhu, Z.; Yu, Y. miRNA-331-3p directly targets E2F1 and induces growth arrest in human gastric cancer. Biochem. Biophys. Res. Commun., 2010, 398, 1-6.
20. Lu, J.; Getz, G.; Miska, E. A.; Alvarez-Saavedra, E.; Lamb, J.; Peck, D.; Sweet-Cordero, A.; Ebert, B. L.; Mak, R. H.; Ferrando, A. A.; Downing, J. R.; Jacks, T.; Horvitz, H. R.; Golub, T. R. MicroRNA expression profiles classify human cancers. Nature, 2005, 435, 834-838.
21. Volinia, S.; Calin, G. A.; Liu, C. G.; Ambs, S.; Cimmino, A.; Petrocca, F.; Visone, R.; Iorio, M.; Roldo, C.; Ferracin, M.; Prueitt, R. L.; Yanaihara, N.; Lanza, G.; Scarpa, A.; Vecchione, A.; Negrini, M.; Harris, C. C.; Croce, C. M. A microRNA expression signature of human solid tumors defines cancer gene targets. Proc. Natl. Acad. Sci. USA, 2006, 103, 2257-2261.
22. Sethupathy, P.; Megraw, M.; Hatzigeorgiou, A. G. A guide through present computational approaches for the identification of mammalian microRNA targets. Nat Methods, 2006, 3, 881-886.
23. Saito, Y.; Friedman, J. M.; Chihara, Y.; Egger, G.; Chuang, J. C.; Liang, G. Epigenetic therapy upregulates the tumor suppressor microRNA-126 and its host gene EGFL7 in human cancer cells. Biochem. Biophys. Res. Commun, 2009, 379, 726-731.
24. Luo, Z.; Zhang, L.; Li, Z.; Li, X.; Li, G.; Yu, H.; Jiang, C.; Dai, Y.; Guo, X.; Xiang, J. An in silico analysis of dynamic changes in microRNA expression profiles in stepwise development of nasopharyngeal carcinoma. BMC Med. Genomics, 2012, 5, 3.
25. Thayanithy, V.; Sarver, A. L.; Kartha, R. V.; Li, L.; Angstadt, A. Y.; Breen, M.; Steer, C. J.; Modiano, J. F.; Subramanian, S. Perturbation of 14q32 miRNAs-cMYC gene network in osteosarcoma. Bone, 2012, 50, 171-181.